Middle Molecule Find

Rulebook › V-tags › V548

V548 Plan: ESAs at home

Written V0548 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.90(a)(4) · Appendix H Rev. 246, page 233 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.90(a) Standard: Development of patient plan of care. …The plan of care must address, but not be limited to, the following: (4) Anemia… For a home dialysis patient, the facility must evaluate whether the patient can safely, aseptically, and effectively administer erythropoiesis-stimulating agents and store this medication under refrigeration if necessary…

Read 42 CFR 494.90 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.90(a)(4)

Note: this guidance is a continuation of the regulatory requirement at § 494.90(a)(4).

An evaluation of the home dialysis patient’s knowledge and competency in safely and effectively administering ESAs should be conducted by a qualified team member who is authorized to train and administer the medication. The dialysis industry typically conducts evaluations through a home dialysis nurse. Use this tag if issues specifically related to the safe use and storage of ESAs are identified. Refer to the Condition for care at home at V585.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 233 (the full 469-page PDF) before quoting it.

Questions on this site that cite it

Rulebook subjects that cite it